Hola Prime Plans to Enter Futures Trading to Solve One of Finance’s Most Persistent Problems: Complexity 
sureWin Nominated for Best iGaming Platform 2025 in SiGMA Awards 
Data Watts Announces CRCO Appointment 
DCLI Drives Fleet Efficiencies with BlackBerry Radar Deployment Across 100,000 Chassis XPhyto Adds Mescaline Production to Psychedelic Medicine Programs
VANCOUVER, BC / ACCESSWIRE / February 10, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or…
American IRA Discusses Understanding the History of Precious Metals in Self-Directed IRAs
ASHEVILLE, NC / ACCESSWIRE / February 10, 2021 / Precious metals have a long history as…
AEX Provides an Update on Its Nalunaq Development
TORONTO, ON / ACCESSWIRE / February 10, 2021 / AEX Gold Inc. (AIM:AEXG)(TSXV:AEX), provides an…
Hemogenyx Pharmaceuticals PLC Announces Allotment of Shares
LONDON, UK / ACCESSWIRE / February 10, 2021 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) announces that…
Atalaya Mining PLC Announces Appointment of Director
NICOSIA, CYPRUS / ACCESSWIRE / February 10, 2021 / Atalaya Mining Plc (AIM:ATYM)(TSX:AYM) is pleased…
Miranda Evans Appointed As Marketing Manager For Zylpha’s ‘Pay As You Bundle’ Software
Zylpha (www.zylpha.com) has appointed Miranda Evans as Marketing Manager for its widely acclaimed ‘Pay As…
Secureworks Unveils Secureworks Taegis™, XDR Advancements, and MSSP Partner Initiative to Strengthen Cybersecurity Community
Secureworks marshals software, brand and channel to protect enterprises and fight adversaries at scale Secureworks…
Update on vaccine production at BioNTech’s manufacturing site in Marburg
MAINZ, GERMANY, February 10, 2021 (GLOBE NEWSWIRE) – We started the manufacturing process at the…
SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman to support its novel vaccine platform through accelerated clinical development
SpyBiotech has raised $32.5M from leading investors to advance development of its novel “plug and…
Biophytis Announces Pricing of $20.1 Million U.S. Initial Public Offering of American Depositary Shares and Approval to List on Nasdaq Capital Market
PARIS and CAMBRIDGE, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) — Biophytis (Euronext Growth Paris: ALBPS)…
Biophytis Announces Temporary Trading Halt of its Ordinary Shares and Share Warrants on Euronext Growth
PARIS and CAMBRIDGE, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) — Biophytis (Euronext Growth Paris: ALBPS)…
PCI Biotech – release of the RNA Therapeutics Virtual Conference presentation
Oslo (Norway), 10 February 2021 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing…
Etesevimab (JS016) Administered with Bamlanivimab Receives FDA Emergency Use Authorization for COVID-19
Etesevimab and bamlanivimab administered together is authorized for treatment of recently diagnosed, mild to moderate…
Iterum Therapeutics plc Announces $35.0 Million Registered Direct Offering of Ordinary Shares Priced At-the-Market under Nasdaq Rules
DUBLIN, Ireland and CHICAGO, Feb. 09, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM)…
Assertio Holdings, Inc. Announces Pricing of $34.3 Million Registered Direct Offering
LAKE FOREST, Ill., Feb. 10, 2021 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
ObsEva Provides Business Outlook for 2021
GENEVA, Switzerland and BOSTON, MA (February 10, 2021) – ObsEva SA (NASDAQ: OBSV; SIX:…
Basilea reports positive topline results from phase 2 study FIDES-01 for derazantinib in FGFR2 gene fusion-positive patients with bile duct cancer (iCCA)
Clinical proof of concept achieved for derazantinib monotherapy in FGFR2 gene fusion-positive iCCA 20.4% objective…
Autolus Announces Pricing of Public Offering
LONDON, Feb. 09, 2021 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical…
Vallon Pharmaceuticals Announces Pricing of Initial Public Offering
PHILADELPHIA, PA, Feb. 09, 2021 (GLOBE NEWSWIRE) — Vallon Pharmaceuticals, Inc. (the “Company”), a clinical-stage…
Enlivex Increases Previously Announced Bought Deal Offering to Approximately $46.0 Million of Ordinary Shares
Nes Ziona, Israel, Feb. 09, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (NASDAQ: ENLV), a…